RTW Biotech Opportunities (LON: RTW) stock: the official figures
RTW Biotech Opportunities (RTW BIOTECH OPPORTUNITIES LTD) is listed on the London Stock Exchange under the ticker RTW and belongs to the financials sector. In fiscal 2025 it reported a net profit of $245.2m, according to the annual accounts it filed with the regulator.
Identifiers for RTW Biotech Opportunities: LEI 549300Q7EXQQH6KF7Z84.
Fiscal 2025 figures
| Item | 2025 | 2024 | Change |
|---|---|---|---|
| Net profit | $245.2m | $34.2m | +617.4% |
| Total assets | $1,069m | $760.0m | +40.7% |
| Cash | $6.0m | $5.4m | +11.7% |
| Operating cash flow | $105.3m | −$124.3m | — |
Margins are calculated from the filed figures: operating profit and net profit over revenue.
5 fiscal years
| Fiscal year | Net profit | Document |
|---|---|---|
| 2025 | $245.2m | Annual report |
| 2024 | $34.2m | Annual report |
| 2023 | $83.2m | Annual report |
| 2022 | −$39.4m | Annual report |
| 2021 | −$64.3m | — |
The full income statement, balance sheet and cash flow statement are in the annual accounts of RTW Biotech Opportunities.
Frequently asked questions about RTW Biotech Opportunities
- How much did RTW Biotech Opportunities earn in fiscal 2025?
- RTW Biotech Opportunities reported a net profit of $245.2m for fiscal 2025. The year before it reported a net profit of $34.2m.
- Where is RTW Biotech Opportunities listed?
- RTW Biotech Opportunities is listed on the London Stock Exchange under the ticker RTW and belongs to the financials sector.
- Where do the figures for RTW Biotech Opportunities come from?
- From the report RTW Biotech Opportunities files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.
Where each figure comes from
The annual accounts come from the report RTW Biotech Opportunities files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year in the table links to its filing. Celsmar reads the tagged figures from the document and does not adjust them: if an item is not in the filing, it is not shown. More detail in data sources and, if you spot an error, in corrections. What Celsmar is and what it costs, in its fact sheet.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.